Showing results (191-200 of 309) with videos related to
Sort By:
Pageof 31
European Journal of Haematology|December 24, 2022
Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysisYoussef Soliman, Ahmed Abdelaziz, Adel Mouffokes, et al.Osteoarthritis and Cartilage|October 4, 2015
Association between hospital procedure volume and risk of revision after total hip arthroplasty: a population-based study within the Nordic Arthroplasty Register Association databaseE N Glassou, T B Hansen, K Mäkelä, et al.Pediatric Blood & Cancer|April 20, 2022
GRAPES: Trivia game increases sickle cell disease knowledge in patients and providers and mitigates healthcare biasesAmy Ouyang, Manasa Gadiraju, Veda Gadiraju, et al.RSC Medicinal Chemistry|August 26, 2024
Cornulacin: a new isoflavone from <i>Cornulaca monacantha</i> and its isolation, structure elucidation and cytotoxicity through EGFR-mediated apoptosisAhmed M Badawy, Enas E Eltamany, Rodina M Hussien, et al.Pain|September 21, 2023
A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trialTonya M Palermo, Chitra Lalloo, Chuan Zhou, et al.Organic & Biomolecular Chemistry|August 13, 2024
Dual SARS-CoV-2 and MERS-CoV inhibitors from <i>Artemisia monosperma</i>: isolation, structure elucidation, molecular modelling studies, and <i>in vitro</i> activitiesAhmed M Badawy, Marwa Samir M Donia, Nehal G Hamdy, et al.Pediatric Blood & Cancer|March 10, 2020
Impact of Medicaid expansion on access and healthcare among individuals with sickle cell diseaseMariam Kayle, Jhaqueline Valle, Susan Paulukonis, et al.British Poultry Science|August 23, 2023
Adenovirus type D and type E infection in broiler chickens: the effect on CD4 and CD8 T cell response, cytokines expression and their immunopathologyG A Abdel-Alim, S M Aly, M S Khattab, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and ApoptosisMedhat Taha, Sara T Elazab, Alaa M Badawy, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918Medhat Taha, Sara T Elazab, Alaa M Badawy, et al.Pageof 31